Hypofractionated radiotherapy for invasive bladder cancer.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Radiotherapy and Oncology

• Publication date

  1997-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0167-8140(96)01893-2PMID 9192962
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bladder cancer definitive radiation therapy of muscle‐invasive bladder cancer: A retrospective analysis of 317 patients

  1993cited by this paper
• Regression of transitional cell carcinoma of the bladder with radiotherapy: progression-free control in the bladder at 5 years.

  1993cited by this paper
• T1 and T2 carcinoma of the urinary bladder: long term results with external, preoperative, or interstitial radiotherapy.

  1992cited by this paper
• The management of invasive transitional cell carcinoma of the bladder. Results of definitive and preoperative radiation therapy in 390 patients treated at the prince of Wales hospital, Sydney, Australia

  1992cited by this paper
• Radical radiotherapy with salvage surgery for invasive bladder cancer: results following a reduction in radiation dose.

  1992cited by this paper
• Short-term radiotherapy as palliative treatment in patients with transitional cell bladder cancer.

  1991cited by this paper
• Dose fractionation and tumour repopulation in radiotherapy for bladder cancer.

  1991cited by this paper
• Radical external beam radiotherapy for localised carcinoma of the prostate using a hypofractionation technique.

  1991cited by this paper
• Prognostic factors in patients with bladder carcinoma treated with definitive irradiation

  1990cited by this paper
• The linear-quadratic formula and progress in fractionated radiotherapy.

  1989cited by this paper
• Tolerance of pelvic normal tissues to hyperfractionated radiation therapy: results of Protocol 83-08 of the Radiation Therapy Oncology Group.

  1988cited by this paper
• The results of a series of 963 patients with transitional cell carcinoma of the urinary bladder primarily treated by radical megavoltage X-ray therapy.

  1986cited by this paper
• Results of surgery following radical radiotherapy for invasive bladder cancer.

  1986cited by this paper
• Primary radical radiotherapy for T3 transitional cell cancer of the bladder: an analysis of survival and control.

  1986cited by this paper
• Cancer statistics, 1985

  1985cited by this paper
• Radical irradiation of T2 grade III and T3 bladder cancer--tumor response and prognosis.

  1983cited by this paper
• Treatment of T3 bladder cancer: controlled trial of pre-operative radiotherapy and radical cystectomy versus radical radiotherapy.

  1982influential reference
• Conservation of bladder function in patients with invasive bladder cancer treated by definitive irradiation and selective cystectomy.

  1981cited by this paper
• T3 bladder cancer--the case for salvage cystectomy.

  1980cited by this paper
• The management of deeply infiltrating (T3) bladder carcinoma: controlled trial of radical radiotherapy versus preoperative radiotherapy and radical cystectomy (first report).

  1976cited by this paper
• Bladder cancer: results of radiation therapy in 384 patients.

  1975cited by this paper
• Efficacy of linear accelerator x-ray therapy in cancer of the bladder.

  1967cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• The role of radiation therapy for de novo metastatic bladder and renal cancers.

  2023cites this paper
• Combining chemotherapy and tislelizumab with preoperative split-course hypofraction radiotherapy for locally advanced rectal cancer: study protocol of a prospective, single-arm, phase II trial

  2023cites this paper
• Muscle-invasive Bladder Cancer in the Elderly Patient With a Focus on Hypofractionated Radiotherapy.

  2021cites this paper
• Is Ultra Hypofractionated Radiation Therapy a Safe and Effective Treatment for Invasive Bladder Cancer in the Elderly?

  2021cites this paper
• Role of radiotherapy in the management of bladder cancer: Recommendations of the French society for radiation oncology.

  2021cites this paper
• The role of palliative radiotherapy in bladder cancer: a narrative review.

  2020cites this paper
• Chemotherapy-based split stereotactic body radiation therapy for borderline resectable and locally advanced pancreatic cancer: study protocol of a prospective, single-arm phase II trial

  2020cites this paper
• Palliative radiation therapy in bladder cancer: a matter of dose, techniques and patients' selection.

  2019cites this paper
• Review of hypo-fractionated radiotherapy for localized muscle invasive bladder cancer.

  2019cites this paper
• Clinical Outcomes of Image Guided Adaptive Hypofractionated Weekly Radiation Therapy for Bladder Cancer in Patients Unsuitable for Radical Treatment

  2017cites this paper
• Wann ist der Primärtumor eines Harnblasen- bzw. Prostatakarzinoms in der metastasierten Situation durch eine nicht-operative Maßnahme zu therapieren?

  2017cites this paper
• Radiation-Induced Toxicity and Related Management Strategies in Urological Malignancies

  2017cites this paper
• Hemostatic radiotherapy in advanced bladder cancer: a single-institution experience

  2017cites this paper
• Principles of Palliative Radiation Therapy

  2017cites this paper
• Hypofractionation versus conventional radiotherapy with concurrent Gemcitabine in bladder preservation of patient with bladder carcinoma

  2016cites this paper
• Long-term results of a concomitant boost radiotherapy technique for elderly patients with muscle-ınvasive bladder cancer.

  2015cites this paper
• Hypofractionated palliative radiotherapy for bladder cancer

  2015cites this paper
• Hypofractionated radiation therapy for treatment of bladder carcinoma in patients aged 90 years and more: A new paradigm to be explored?

  2015cites this paper
• Current approaches to the management of bladder cancer in older patients.

  2014cites this paper
• The role of hypofractionated radiation in the management of non-osseous metastatic or uncontrolled local cancer.

  2014cites this paper
• HYBRID - evaluating new radiation technology in patients with unmet needs.

  2013cites this paper
• Toxicidad cutánea a corto plazo de pacientes con cáncer de mama tratados con radioterapia hipofraccionada

  2013cites this paper
• The efficacy of hemostatic radiotherapy for bladder cancer-related hematuria in patients unfit for surgery.

  2013cites this paper
• Evaluation of acute toxicity and symptoms palliation in a hypofractionated weekly schedule of external radiotherapy for elderly patients with muscular invasive bladder cancer.

  2013cites this paper
• A weekly hypofractionated radiotherapeutic schedule for bladder carcinoma in elderly patients: local response, acute and late toxicity, dosimetric parameters and pain relief.

  2013cites this paper
• Evaluation of efficacy and toxicity in two different hypofractionated 3 D-conformal external beam radiotherapy schedules in localised muscle invasive bladder cancer

  2013influential citation
• Curative Intent Versus Palliative Intent Radiation Oncology

  2013cites this paper
• Evaluation of efficacy and toxicity in two different hypofractionated 3D-conformal external beam radiotherapy schedules in localised muscle invasive bladder cancer.

  2013influential citation
• Radio-chemotherapy for bladder cancer: Contribution of chemotherapy on local control.

  2013cites this paper
• Ruolo Della Radioterapia Nei Tumori Urologici Localmente Avanzati e/o Recidivati

  2013cites this paper
• Treatment of invasive bladder cancer with conformal hypofractionated accelerated radiotherapy and amifostine (HypoARC).

  2012cites this paper
• A hypofractionated radiotherapy regimen (0-7-21) for advanced gynaecological cancer patients.

  2011cites this paper
• Hypofractionated whole-brain radiotherapy for multiple brain metastases from transitional cell carcinoma of the bladder.

  2010cites this paper
• Palliative Radiotherapy: When Is It Worth It and When Is It Not?

  2010cites this paper
• Radiation dose-volume effects of the urinary bladder.

  2010cites this paper
• Neoadjuvant Chemotherapy: The New Standard

  2009cites this paper
• Carcinoma of the bladder

  2008cites this paper
• A review of hypofractionated palliative radiotherapy

  2007cites this paper
• Radical hypofractionated accelerated radiotherapy with cytoprotection for invasive bladder cancer.

  2007cites this paper
• Radical radiotherapy for invasive bladder cancer: What dose and fractionation schedule to choose?

  2006cites this paper
• Radical radiotherapy for urinary bladder cancer: treatment outcomes

  2006cites this paper
• Radiation therapy for muscle-invasive bladder cancer: treatment planning and delivery in the 21st century.

  2005cites this paper
• Radiation therapy for muscle-invasive bladder cancer: treatment planning and delivery.

  2005cites this paper
• Novel therapies in bladder cancer.

  2005cites this paper
• Palliative radiation therapy.

  2005cites this paper
• Current Status of Radiation Therapy and Combined-Modality Treatment for Bladder Cancer

  2004cites this paper
• Chemoradiotherapy as a bladder-preservation approach for muscle-invasive bladder cancer: current status and perspectives

  2004cites this paper
• Concurrent chemoradiotherapy for clinical stage T2 bladder cancer: report of a single institution.

  2004cites this paper
• Concomitant boost radiotherapy for muscle invasive bladder cancer.

  2003cites this paper
• The role of chemotherapy and radiation in organ-preservation strategies for muscle-invasive bladder cancer

  2002cites this paper
• [External radiotherapy].

  2002cites this paper
• Radiotherapy for Carcinoma of the Bladder

  2001cites this paper
• High dose daily amifostine and hypofractionated intensively accelerated radiotherapy for locally advanced breast cancer. A phase I/II study and report on early and late sequellae.

  2001cites this paper
• Radiotherapy for Carcinoma of the Bladder: A Review

  2001cites this paper
• A randomized trial of hypofractionated schedules of palliative radiotherapy in the management of bladder carcinoma: results of medical research council trial BA09.

  2000cites this paper
• Radiotherapy in bladder cancer.

  1999cites this paper
• Comparison between the clonogenic, MTT, and SRB assays for determining radiosensitivity in a panel of human bladder cancer cell lines and a ureteral cell line.

  1999cites this paper
• Heterogeneity of in vitro radiosensitivity in human bladder cancer cells.

  1999cites this paper
• World Journal of Surgical Oncology Open Access Neuroendocrine Carcinoma Arising in Soft Tissue: Three Case Reports and Literature Review

  year unknowncites this paper